<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=217082&amp;fmt=gif">
Our response to COVID-19: Our laboratories remain open and committed to providing research services for preclinical, translational and clinical phase programs. 

CNS Models & Services

Cutting-edge neurological and CNS research services are offered through our Neuroscience Research Laboratories. Our facilities are fitted with state-of-the-art equipment and technologies for preclinical and translational studies, featuring clinically-relevant read outs and endpoints. Specialties include studies of neuropathic, acute and chronic pain and neurodegenerative/neuroinflammatory diseases. Unique pig translational models and electrophysiology capabilities compliment rodent capabilities and accelerate your program towards their next objectives and milestones. 




Immunology Models & Services

In-depth understanding of immunology and inflammatory processes form a cornerstone of MD Biosciences. Our laboratories offer a range of validated models including many inflammatory diseases involving skin, gastro-intestinal, respiratory, joint inflammation as well as sepsis. Each disease area is served extensively by different models and batteries of in vitro and ex vivo analyses, offering answers to your candidate therapeutics/ effect on different parameters. Our inflammatory disease models serve as the basis for comprehensive biomarker analysis, providing unrivaled ability to nuance the effect of compounds at each disease stage. Methods include state-of-the-art flow cytometry, picogram level proteomic analytics, qPCR, automated Western Blot and multiplexed protein analysis.


Clinical Services

MD Biosciences CLIA Clinical Laboratory Services Division specializes in the development, validation and operation of highly complex biomarker analyses in support of clinical studies. Technological capabilities include multiplexed molecular and proteomic biomarker analysis, assay development and CLIA-validation as well as central laboratory functionality for clinical trial testing and consultations. Advanced methodologies include multiparameter flow cytometry, qPCR, Western Blot and multiplexed proteomics performed on all types of samples including tissue, blood, urine, fecal and hair samples.



Histology/IHC Services

MD Biosciences operates two distinct histology and IHC laboratories, including a GLP developmental research laboratory and a CLIA clinical IHC laboratory, offering a broad range of state-of-the-art technical capabilities to meet research and clinical study needs. Method development and optimization in addition to routine analysis shapes the foundation for our tissue-based services. The laboratories are equipped with advanced automated staining systems and digitized imaging, facilitating the privileged access to large, annotated image files. Services are complimented by the Visiopharm artificial intelligence-based image analysis platform to enhance the quality and speed of analysis. Services are supported by expert consultant pathologists specialized in various areas. 


Have Questions? Contact us!


Announcing MLM Medical Labs' Acquisition of MD Biosciences, Inc.

Oct 26, 2020 10:06:56 AM

We are happy to announce that we have merged with MLM Medical Labs ("MLM"), a specialized ... Read More

LPS-induced Lung Injury and Fibrosis Models for COVID-19 Therapeutic Developments

Sep 29, 2020 2:51:28 PM

Most severe COVID-19 patients develop pneumonia and hyper-inflammation, likely Read More

Upcoming Events

Coming Soon!



Contact us to Inquire about registration options: info-us@mdbiosciences.com